Search Results - "Marroquin Belaunzaran, Osiris"
-
1
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-10-2012)“…Objective Spondylarthritides (SpA), including ankylosing spondylitis (AS), are common inflammatory rheumatic diseases that are strongly associated with…”
Get full text
Journal Article -
2
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats
Published in PloS one (30-06-2015)“…HLA-B27 is a common genetic risk factor for the development of Spondyloarthritides (SpA). HLA-B27 can misfold to form cell-surface heavy chain homodimers…”
Get full text
Journal Article -
3
Chronic delivery of antibody fragments using immunoisolated cell implants as a passive vaccination tool
Published in PloS one (20-04-2011)“…Monoclonal antibodies and antibody fragments are powerful biotherapeutics for various debilitating diseases. However, high production costs, functional…”
Get full text
Journal Article -
4
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Published in Journal of translational medicine (12-08-2013)“…Malignant pleural mesothelioma (MPM) is an incurable malignant disease, which results from chronic exposition to asbestos in at least 70% of the cases…”
Get full text
Journal Article -
5
IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity
Published in Cancers (21-08-2024)“…HLA-B27 and HLA-B57 are associated with autoimmunity and long-term viral control and protection against HIV and HCV infection; however, their role in cancer…”
Get full text
Journal Article -
6
865 iosH2 exerts potent anti-tumor activity by blocking LILRB1/2 and KIR3DL1 receptor signaling
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundTo develop novel anti-cancer therapeutics we have used a reverse rational approach and searched for human HLA class I molecules known to induce…”
Get full text
Journal Article -
7
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
Published in Journal for immunotherapy of cancer (07-11-2013)“…IntroductionMalignant pleural mesothelioma (MPM) is an incurable malignant disease that results mostly from chronic exposition to asbestos. Fibroblast…”
Get full text
Journal Article -
8
Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e14137 Background: HLA open conformers (OC) are defined as HLA class I molecules lacking beta-2-microglobulin (β2m) and peptide. OC can be…”
Get full text
Journal Article -
9
216 Anti-tumor activity of iosH2 by blocking LILRB2 receptor signalling
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundThe human leukocyte immunoglobulin-like receptor family B (LILR B) acts as check point blockade of the innate immune system by inhibiting leukocyte…”
Get full text
Journal Article -
10
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply
Published in Annals of the rheumatic diseases (01-04-2014)“…Cellular expression of non-classical forms of human leukocyte antigen (HLA)-B27 (NC-B27) may be involved in spondyloarthritis (SpA) pathogenesis. We used a…”
Get more information
Journal Article -
11
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats: e0130811
Published in PloS one (01-06-2015)“…Objectives HLA-B27 is a common genetic risk factor for the development of Spondyloarthritides (SpA). HLA-B27 can misfold to form cell-surface heavy chain…”
Get full text
Journal Article